Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.

Huang J, Chen K, Chen J, Gong W, Dunlop NM, Howard OM, Gao Y, Bian XW, Wang JM.

Br J Cancer. 2010 Mar 16;102(6):1052-60. doi: 10.1038/sj.bjc.6605591.

2.

Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.

Zhou Y, Bian X, Le Y, Gong W, Hu J, Zhang X, Wang L, Iribarren P, Salcedo R, Howard OM, Farrar W, Wang JM.

J Natl Cancer Inst. 2005 Jun 1;97(11):823-35.

PMID:
15928303
3.

Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.

Huang J, Chen K, Huang J, Gong W, Dunlop NM, Howard OM, Bian X, Gao Y, Wang JM.

Carcinogenesis. 2009 Feb;30(2):348-55. doi: 10.1093/carcin/bgn266.

4.

Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.

Yao XH, Ping YF, Chen JH, Chen DL, Xu CP, Zheng J, Wang JM, Bian XW.

J Neurooncol. 2008 Jan;86(1):47-53.

PMID:
17611713
5.

Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.

Huang J, Hu J, Bian X, Chen K, Gong W, Dunlop NM, Howard OM, Wang JM.

Cancer Res. 2007 Jun 15;67(12):5906-13.

6.

Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR.

Yao XH, Ping YF, Chen JH, Xu CP, Chen DL, Zhang R, Wang JM, Bian XW.

J Pathol. 2008 Aug;215(4):369-76. doi: 10.1002/path.2356.

PMID:
18523971
7.

Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1.

Yang Y, Liu Y, Yao X, Ping Y, Jiang T, Liu Q, Xu S, Huang J, Mou H, Gong W, Chen K, Bian X, Wang JM.

Am J Pathol. 2011 Sep;179(3):1504-12. doi: 10.1016/j.ajpath.2011.05.059. Erratum in: Am J Pathol. 2011 Nov 1;179(5):2674. Ming Wang, Ji [corrected to Wang, Ji Ming].

8.

Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion.

Toussaint LG 3rd, Nilson AE, Goble JM, Ballman KV, James CD, Lefranc F, Kiss R, Uhm JH.

Mol Cancer. 2012 May 14;11:32. doi: 10.1186/1476-4598-11-32.

9.

Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.

Chen DL, Ping YF, Yu SC, Chen JH, Yao XH, Jiang XF, Zhang HR, Wang QL, Bian XW.

Biochem Biophys Res Commun. 2009 Apr 10;381(3):448-52. doi: 10.1016/j.bbrc.2009.02.065.

PMID:
19233142
10.

[Effect of nordy on FPR function of malignant human glioma cell line U87].

Chen JH, Bian XW, Yao XH, Yang SX, Xu CR, Zhou XD, Ping YF.

Yao Xue Xue Bao. 2007 Mar;42(3):257-62. Chinese.

PMID:
17520823
11.

Human malignant glioma cells expressing functional formylpeptide receptor recruit endothelial progenitor cells for neovascularization.

Xu CP, Zhang HR, Chen FL, Yao XH, Liang ZQ, Zhang R, Cui Y, Qian C, Bian XW.

Int Immunopharmacol. 2010 Dec;10(12):1602-7. doi: 10.1016/j.intimp.2010.09.016.

PMID:
20933627
12.

Biologically active peptides interacting with the G protein-coupled formylpeptide receptor.

Le Y, Wang JM, Liu X, Kong Y, Hou X, Ruan L, Mou H.

Protein Pept Lett. 2007;14(9):846-53. Review.

PMID:
18045224
13.

[Activation of formylpeptide receptor in human malignant glioma cells and its effects on cell proliferation and production of angiogenic factors].

Yao XH, Bian XW, Ping YF, Chen JH, Wang QL, Jiang XF.

Ai Zheng. 2007 Mar;26(3):241-6. Chinese.

PMID:
17355784
14.

Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.

Rutkowski MJ, Sughrue ME, Kane AJ, Kim JM, Bloch O, Parsa AT.

J Neurooncol. 2011 Nov;105(2):165-71. doi: 10.1007/s11060-011-0576-7.

PMID:
21503828
16.

Inhibition of U-87 human glioblastoma cell proliferation and formyl peptide receptor function by oligomer procyanidins (F2) isolated from grape seeds.

Zhang FJ, Yang JY, Mou YH, Sun BS, Ping YF, Wang JM, Bian XW, Wu CF.

Chem Biol Interact. 2009 May 15;179(2-3):419-29. doi: 10.1016/j.cbi.2008.12.017.

PMID:
19167369
17.

Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.

Chen JH, Bian XW, Yao XH, Gong W, Hu J, Chen K, Iribarren P, Zhao W, Zhou XD.

Biochem Biophys Res Commun. 2006 Apr 21;342(4):1368-74.

PMID:
16516855
18.

Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression.

Huang J, Chen K, Gong W, Zhou Y, Le Y, Bian X, Wang JM.

Cancer Lett. 2008 Aug 28;267(2):254-61. doi: 10.1016/j.canlet.2008.03.014. Review.

19.

Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1.

Liu S, Yin F, Fan W, Wang S, Guo XR, Zhang JN, Tian ZM, Fan M.

J Exp Clin Cancer Res. 2012 May 31;31:52. doi: 10.1186/1756-9966-31-52.

20.

[Nordy inhibits cell proliferation and angiogenic factor production of malignant human glioma cells mediated by formylpeptide receptor].

Yao XH, Ping YF, Bian XW, Chen JH, Wang QL, Jiang XF.

Zhonghua Yi Xue Za Zhi. 2007 Feb 13;87(7):479-84. Chinese.

PMID:
17459229
Items per page

Supplemental Content

Support Center